Howard C R, Young P R, Lee S, Dixon J, Zuckerman A J, McAleer W J, Lehman E D
J Virol Methods. 1986 Aug;14(1):25-35. doi: 10.1016/0166-0934(86)90004-2.
Hepatitis B micelles containing the p25 component of hepatitis B surface antigen (HBsAg) have been produced by Triton X-100 solubilization followed by ultracentrifugation in linear sucrose gradients. The product was found to resemble micelle forms prepared from plasma-derived HBsAg with the surface being composed of discrete globular and stranded sub-units. The degree of immunochemical relatedness of the micellular preparation was compared to the native 22-nm HBsAg particle present in either plasma or yeast cell extracts. The yeast micelle preparation competed for anti-HBs in a similar manner as intact HBsAg of plasma origin. Enhanced immunogenicity may be expected for micelles containing a recombinant HBsAg protein as has previously been shown for the plasma-derived antigen.
通过Triton X-100增溶,然后在线性蔗糖梯度中进行超速离心,制备了含有乙型肝炎表面抗原(HBsAg)p25成分的乙肝病毒微粒。发现该产物类似于由血浆来源的HBsAg制备的微粒形式,其表面由离散的球状和链状亚基组成。将该微粒制剂的免疫化学相关性程度与血浆或酵母细胞提取物中存在的天然22纳米HBsAg颗粒进行了比较。酵母微粒制剂与血浆来源的完整HBsAg一样,以类似的方式竞争抗HBs。正如先前对血浆来源抗原所显示的那样,含有重组HBsAg蛋白的微粒可能具有增强的免疫原性。